Corporate venture capital has been growing for the past decade as established companies try to access startup innovation without building it internally. The pitch is compelling: invest in promising startups, gain strategic insights and potential acquisition targets, generate financial returns, and signal innovation credentials to the market.

I’ve watched numerous corporate VC initiatives launch with enthusiasm and struggle with execution. The fundamental problem is that corporate VCs serve multiple masters with conflicting objectives. This creates incentive misalignment that’s difficult to resolve and often leads to outcomes that disappoint everyone involved.

The stated goals of corporate VC are usually some combination of financial returns, strategic learning, deal flow for acquisitions, and ecosystem development. These goals aren’t necessarily compatible, and the conflicts become apparent when specific investment decisions need to be made.

A startup that would generate strong financial returns might compete with the corporate parent’s core business, making it strategically problematic. A strategically aligned startup might have limited growth potential or require the corporate parent as primary customer, creating dependence that reduces financial upside. An interesting technology might be better acquired than invested in, but acquisition timing might not align with the startup’s interests.

The corporate VC fund manager faces an impossible situation. They’re evaluated on financial returns (like traditional VCs) but also on strategic value contribution (however that’s defined). When these conflict, which takes priority? The answer varies by organization, often based on who’s currently in leadership and what their priorities are.

This creates uncertainty for portfolio companies. A startup takes corporate VC investment expecting patient capital and strategic support. Then the corporate VC’s leadership changes, strategic priorities shift, and suddenly the fund is focused on near-term exits rather than long-term value creation. Or the corporate parent decides to compete directly with the portfolio company’s product, creating an adversarial relationship.

Information asymmetry is another challenge. Corporate VCs typically want deep visibility into portfolio companies—product roadmaps, customer lists, technical architecture—to generate strategic value. But startups need to protect competitive information, particularly if the corporate investor competes in adjacent markets or might become a competitor.

I’ve seen startups become reluctant to share information with their corporate investor because they fear it will be used competitively. The corporate investor becomes frustrated because they’re not getting the strategic insights they invested to access. The relationship deteriorates despite aligned financial interests.

Board governance creates additional conflicts. Corporate VCs often want board seats to maintain oversight and strategic involvement. But corporate board representatives face conflicts when portfolio company interests diverge from parent company interests. Do they advocate for what’s best for the startup or what’s best for their employer?

These conflicts become acute during acquisition discussions. If the corporate parent wants to acquire a portfolio company, the corporate VC board representative should negotiate for best terms for the startup and its shareholders. But they work for the potential acquirer, creating an obvious conflict. Independent board members and other investors often push to exclude corporate VCs from acquisition negotiations, but this creates tension and suggests the corporate investor can’t be trusted.

Decision-making speed is problematic for many corporate VCs. Startups move quickly and need fast investment decisions. Corporate VCs often need multiple internal approval layers, particularly for larger investments or strategic deals. By the time corporate VC gets internal approval, the startup has closed its round with other investors or circumstances have changed.

Fund structure also creates issues. Traditional VC funds have 10-year terms with specific return expectations and defined exit timeframes. Corporate VC funds sometimes operate as evergreen vehicles without clear exit timeline. This can be advantageous (patient capital) or problematic (no urgency to drive value creation).

Some corporate VCs are structured as innovation labs or strategic investment teams reporting to business units rather than as independent funds. This tightens strategic alignment but often sacrifices investment discipline. Business units want investments that support their short-term priorities rather than maximizing long-term value.

The most effective corporate VC programs I’ve observed maintain strong separation between the investment function and parent company operations. The fund has independent decision-making authority, professional VC expertise on the team, and clear governance to manage conflicts. Strategic value flows through information sharing and partnership opportunities, not through control or preferential treatment.

But this separation reduces the strategic value that justified creating the corporate VC in the first place. If the fund operates independently and makes decisions purely on financial merit, why not just invest in a traditional VC fund that specializes in the relevant sector?

There’s also a track record issue. Many corporate VC programs shut down after a few years when returns disappoint or strategic value fails to materialize. This creates uncertainty for startups considering corporate VC investment—will this corporate investor still be active in three years when the startup needs follow-on funding?

Some corporates use their VC arm primarily for deal flow—sourcing potential acquisitions early and building relationships before making offers. This is strategically rational from the corporate perspective but creates risk for startups. Did the corporate investor really believe in our potential, or were they just conducting extended due diligence before an acquisition attempt?

The power dynamics are often asymmetric. The corporate investor typically takes a minority position and doesn’t control the company, but they have significant leverage through potential strategic partnerships, customer relationships, or acquisition interest. Startups sometimes make business decisions to please their corporate investor rather than because it’s objectively the best strategy.

When working with Team400 on governance frameworks for corporate innovation programs, we developed guidelines for when corporate VC makes sense versus alternative approaches like strategic partnerships, accelerator programs, or technology licensing. Corporate VC is rarely the optimal approach for all situations.

For startups considering corporate VC investment, due diligence on the investor is critical. What’s their track record with previous portfolio companies? Do founders report positive experiences or cautionary tales? How are conflicts managed? What happens when strategic priorities change? Are there examples of the corporate parent competing with portfolio companies?

For corporates considering launching VC programs, honest assessment of objectives and capabilities is essential. If the primary goal is financial returns, invest in traditional VC funds and build relationships with their portfolio companies. If the goal is strategic learning, consider advisory boards, pilot programs, or partnerships rather than equity investment. If the goal is acquisition pipeline, be transparent about that intent and structure programs accordingly.

Corporate venture capital can work when objectives are clear, conflicts are managed transparently, and professional investment expertise guides decision-making. But too often it’s launched for signal value (we’re innovative!) without realistic assessment of whether corporate structure and incentives support effective VC investing.

The graveyard of failed corporate VC programs is large and growing. Before launching another one, corporates should deeply examine whether they can avoid the conflicts and organizational challenges that have derailed most previous attempts. And startups should carefully evaluate whether corporate VC investment brings enough strategic value to justify the risks of complex incentive alignment and potential future conflicts.